Bloomberg Businessweek

(Bloomberg) -- Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Asthika Goonewardene Senior Analyst:Biotech Bloomberg Intelligence Discussing Gilead Sciences Inc. agreed to buy Kite Pharma Inc. for about $11.9 billion, making one of its biggest deals ever to expand beyond its eroding hepatitis C drug franchise.